Physician profile
Grace Huynh
NPI 1417563149
$1,984.73
in general payments reported to CMS, 2019-2025
12 companies · $539 in 2025
The $539 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $300 · 2023: $378 · 2024: $604 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.74 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $777.74 | 2021-2025 | Acuvue |
| Alcon Vision LLC | $330.57 | 2021-2025 | Clareon, Clareon Panoptix Pro |
| Oyster Point Pharma, INC. | $306.44 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $140.00 | 2023 | |
| Bausch & Lomb Americas INC. | $93.73 | 2024 | Xiidra, Miebo |
| Coopervision INC. | $91.78 | 2025 | Clariti Contact Lens |
| Rxsight INC | $81.32 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Carl Zeiss Meditec USA, INC. | $78.09 | 2021-2024 | Visumax |
| Gilead Sciences, INC. | $23.55 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.13 | 2023 | |
| Sun Pharmaceutical Industries INC. | $20.29 | 2025 | |
| Sight Sciences, INC. | $18.09 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Huynh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.